期刊
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
卷 31, 期 -, 页码 135-140出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2022.08.018
关键词
Carbapenemase; Drug resistance; Pseudomonas aeruginosa
This study reveals the linages and mechanisms of resistance of Pseudomonas aeruginosa circulating in Peru. The results show that the high-risk P. aeruginosa clones ST357 carrying the novel blaIMP-93 gene and ST111 carrying blaIMP-18 and blaVIM-2 genes have become endemic in the region.
Objectives: Pseudomonas aeruginosa is one of the leading causes of healthcare-associated infections glob-ally. High-risk carbapenemase-encoding P. aeruginosa clones are disseminating in many regions. The aim of this study was to learn more about the lineages and mechanisms of resistance of P. aeruginosa circu-lating in Peru. Methods: A total of 141 carbapenemase-producing isolates recovered from hospitalized and ambulatory patients in Lima were sequenced and analyzed to infer their lineages through whole-genome sequence typing (wgST) and to identify their antimicrobial resistance genes. Results: wgST identified nine sequence types (STs); ST111 and ST357 were the most frequently encoun-tered (44.0% and 38.3%, respectively), followed by ST179 (8.5%), with the remaining six detected only sporadically. Among ST357 isolates, 96.3% carried the novel blaIMP-93 allele, whereas the remainder har-bored blaIMP-74. 74.2% of ST111 isolates co-harbored blaIMP-18 and blaVIM-2, while the rest carried either of these genes individually . All other ST lineages carried a single carbapenemase, which was either blaIMP-16, blaIMP-74, or blaVIM-2. Conclusion: Our study shows that the high-risk P. aeruginosa clones ST357, which harbors the novel blaIMP-93 , and ST111, which carries blaIMP-18 and blaVIM-2 , have apparently become endemic in the region. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据